Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 1 Interventional Results available

A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain Involvement

ClinicalTrials.gov ID: NCT04543188

Public ClinicalTrials.gov record NCT04543188. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 6:14 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A TWO-PART, PHASE 1A/B, OPEN-LABEL, MULTICENTER TRIAL EVALUATING PHARMACOKINETICS, SAFETY AND EFFICACY OF PF 07284890 (ARRY 461) IN PARTICIPANTS WITH BRAF V600 MUTANT SOLID TUMORS WITH AND WITHOUT BRAIN INVOLVEMENT

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

First-in-human study to assess safety, tolerability, PK, and preliminary activity of PF-07284890 as a single agent and in combination with binimetinib in participants with BRAF V600-mutated advanced solid tumor malignancies with and without brain involvement.

Study identification

NCT ID
NCT04543188
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 1
Lead sponsor
Pfizer
Industry
Enrollment
65 participants

Conditions and interventions

Eligibility (public fields only)

Age range
16 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 8, 2021 (Actual)
Primary completion
Mar 20, 2024 (Actual)
Completion
Mar 20, 2024 (Actual)
Last update posted
Oct 23, 2025

2021 – 2024

United States locations

U.S. sites
39
U.S. states
12
U.S. cities
26
Facility City State ZIP Site status
City of Hope (City of Hope National Medical Center, City of Hope Medical Center) Duarte California 91010 —
UCSF Helen Diller Family Comprehensive Cancer Center San Francisco California 94143 —
Orlando Health Cancer Institute Orlando Florida 32806 —
Moffitt Cancer Center Tampa Florida 33612 —
Richard M Schulze Family Foundation Outpatient Center at McKinley Campus Tampa Florida 33612 —
Northwestern Medical Group Chicago Illinois 60611 —
Northwestern Memorial Hospital Chicago Illinois 60611 —
University of Iowa Hospitals and Clinics Iowa City Iowa 52242 —
Johns Hopkins University / Johns Hopkins Hospital Baltimore Maryland 21231 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Ophthalmic Consultants of Boston Inc (OCB) Boston Massachusetts 02114 —
Brigham & Women's Hospital Boston Massachusetts 02115 —
Imaging: Brigham and Women's Hospital Boston Massachusetts 02115 —
Dana-Farber Cancer Institute Boston Massachusetts 02215 —
Imaging: Brigham and Women's Radiology, Coolidge Corner Imaging Brookline Massachusetts 02446 —
Imaging: Brigham and Women's Ambulatory Care Chestnut Hill Massachusetts 02467 —
Imaging: Brigham and Women's Mass General Healthcare Center Foxborough Massachusetts 02035 —
Dana-Farber Cancer Institute - Chestnut Hill Newton Massachusetts 02459 —
Siteman Cancer Center - St Peters City of Saint Peters Missouri 63376 —
Siteman Cancer Center - West County Creve Coeur Missouri 63141 —
Siteman Cancer Center - North County Florissant Missouri 63031 —
Barnes-Jewish Hospital St Louis Missouri 63110 —
Washington University School of Medicine St Louis Missouri 63110 —
Siteman Cancer Center - South County St Louis Missouri 63129 —
Hackensack University Medical Center Hackensack New Jersey 07601 —
John Theurer Cancer Center at Hackensack University Medical Center Hackensack New Jersey 07601 —
MSK Monmouth. Middletown New Jersey 07748 —
MSK Commack Commack New York 11725 —
MSKCC-Westchester (500 Westchester Ave.) Harrison New York 10604 —
Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street). New York New York 10021 —
Rockefeller Outpatient Pavilion (53rd Street) New York New York 10022 —
Memorial Sloan Kettering Cancer Center New York New York 10065 —
UNC Hospitals, The University of North Carolina at Chapel Hill Chapel Hill North Carolina 27514 —
Duke Eye Center Durham North Carolina 27705 —
Duke University Medical Center, Investigational Chemotherapy Services Durham North Carolina 27710 —
Duke University Medical Center Durham North Carolina 27710 —
Tennessee Oncology PLLC Franklin Tennessee 37067 —
Tennessee Oncology PLLC Nashville Tennessee 37203 —
The University of Texas MD Anderson Cancer Center Houston Texas 77030 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04543188, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 23, 2025 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04543188 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →